News

Available by prescription (Xenical) and over the counter (Alli), it is often used with a low-fat diet. While effective, ...
Her Excellency, Dileeni Daniel-Selvaratnam chaired the 5th meeting of Cabinet held on Wednesday April 2, 2025, at the Hon ...
China’s central bank is boosting cash injection via one of its policy tools as it seeks to safeguard the world’s second-largest economy from the impact of punitive US tariffs. The People’s ...
When we talk about identity in cybersecurity, most people think of usernames, passwords, and the occasional MFA prompt. But lurking beneath the surface is a growing threat that does not involve human ...
She has over two years of writing experience and enjoys using her pen for lifestyle, beauty, entertainment and fashion-related matters. She is a graduate from Guru Gobind Singh Indraprastha ...
Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies.
Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies.
Booming sales of the Danish drugmaker’s new obesity and diabetes medicines, delivered in injection pens, have propelled it to become Europe’s most valuable company by market value, at about $572 ...
Regeneron is also expanding its Tarrytown, New York-based facility and building a separate facility in the state to expand capacity to fill injection pens - a process known as fill-finish.